Showing results (171-180 of 277) with videos related to

Sort By:
Pageof 28
International Journal of Cancer|February 1, 2018
Prognostic factors for soft tissue sarcoma patients with lung metastases only who are receiving first-line chemotherapy: An exploratory, retrospective analysis of the European Organization for Research and Treatment of Cancer-Soft Tissue and Bone Sarcoma Group (EORTC-STBSG)Lars H Lindner, Saskia Litière, Stefan Sleijfer, et al.
Frontiers in Oncology|August 4, 2022
Radiomic Features From Diffusion-Weighted MRI of Retroperitoneal Soft-Tissue Sarcomas Are Repeatable and Exhibit Change After RadiotherapyImogen Thrussell, Jessica M Winfield, Matthew R Orton, et al.
American Journal of Physiology. Gastrointestinal and Liver Physiology|August 6, 2011
Gut-derived factors promote neurogenesis of CNS-neural stem cells and nudge their differentiation to an enteric-like neuronal phenotypeSubhash Kulkarni, Bende Zou, Jesse Hanson, et al.
The Journal of Organic Chemistry|October 12, 2007
Preparation of novel unsymmetrical bisindoles under solvent-free conditions: synthesis, crystal structures, and mechanistic aspectsHanns Martin Kaiser, Ivo Zenz, Wei Fun Lo, et al.
Nanoscale|June 25, 2015
Quenching of the upconversion luminescence of NaYF₄:Yb³⁺,Er³⁺ and NaYF₄:Yb³⁺,Tm³⁺ nanophosphors by water: the role of the sensitizer Yb³⁺ in non-radiative relaxationRiikka Arppe, Iko Hyppänen, Niina Perälä, et al.
European Journal of Haematology|April 9, 2010
BSc2118 is a novel proteasome inhibitor with activity against multiple myelomaJan Sterz, Christian Jakob, Ulrike Kuckelkorn, et al.
Blood Cancer Journal|February 24, 2019
Health-related quality of life in the ENDEAVOR study: carfilzomib-dexamethasone vs bortezomib-dexamethasone in relapsed/refractory multiple myelomaHeinz Ludwig, Philippe Moreau, Meletios A Dimopoulos, et al.
Leukemia Research|December 16, 2010
Epigenetic regulation of PAX5 expression in acute T-cell lymphoblastic leukemiaGero Hütter, Martin Kaiser, Martin Neumann, et al.
European Journal of Haematology|February 8, 2012
The novel, orally bioavailable HSP90 inhibitor NVP-HSP990 induces cell cycle arrest and apoptosis in multiple myeloma cells and acts synergistically with melphalan by increased cleavage of caspasesBritta Lamottke, Martin Kaiser, Maren Mieth, et al.
Bulletin De La Societe Des Sciences Medicales Du Grand-Duche De Luxembourg|July 27, 2005
[Limitations and possibilities of applying the positive effects of human/animal relations in the treatment of psychological ailments]Jean-Marie Spautz, Carola Otterstedt, Martin Kaiser, et al.
Pageof 28